Lorvotuzumab
Modify Date: 2024-01-13 15:45:24
Lorvotuzumab structure
|
Common Name | Lorvotuzumab | ||
|---|---|---|---|---|
| CAS Number | 339306-30-8 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LorvotuzumabLorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1]. |
| Name | Lorvotuzumab |
|---|
| Description | Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Lorvotuzumab mertansine (IMGN901) 是一种 ADC，可通过二硫键连接强效抗有丝分裂 (DM1) 与 CD56 靶向抗体 (Lorvotuzumab)。 Lorvotuzumab mertansine 抗肾母细胞瘤、横纹肌肉瘤和神经母细胞瘤。 |
| References |
| No Any Chemical & Physical Properties |
- Shanghai Nianxing Industrial Co., Ltd
- China
- Product Name: Lorvotuzumab
- Price: Negotiable
- Purity: 95.0%
- Delivery: 10 Day
- Contact: Huang
- Email: sales@echemcloud.com
Get all suppliers and price by the below link: